Alberta’s new policy may set a precedent that moves Canadians one step closer to accepting psychedelics as medicinal substances, but historically these drugs were widely sought out for recreational and non-clinical purposes.
The peer-reviewed study, published Monday in the Canadian Medical Association Journal, is significant given recent calls to reduce virtual service over quality-of-care concerns and ER burdens, the researchers write.
